Is there a role for antiplatelet therapy in infective endocarditis? A review of current scientific evidence

被引：1

作者：

Anavekar N.S. ^{[1
]}

Murphy J.G. ^{[1
]}

机构：

[1] Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905

来源：

Current Infectious Disease Reports | 2010年 / 12卷 / 4期

关键词：

Antiplatelet; Aspirin; Embolism; Infection; Infective endocarditis (IE);

D O I：

10.1007/s11908-010-0115-2

中图分类号：

学科分类号：

摘要：

Recently, interest has emerged regarding adjuvant antiplatelet therapy in infective endocarditis (IE) and its impact on clinical outcomes. Despite ongoing research, the role of antiplatelet therapy in this setting remains unclear. Generally, investigations of IE are limited by the low incidence of the disease, practical issues related to diagnosis, and the highly variable latency period between symptom onset and definitive diagnosis. This article reviews the rationale for using antiplatelet therapy in the setting of IE and the contemporary literature that investigates its use. © 2010 Springer Science+Business Media, LLC.

引用

页码：253 / 256

页数：3

共 24 条

[1]

Steckelberg J.M., Murphy J.G., Ballard D., Et al., Emboli in infective endocarditis: The prognostic value of echocardiography, Ann Intern Med, 114, pp. 635-640, (1991)

[2]

Tleyjeh I.M., Steckelberg J.M., Murad H.S., Et al., Temporal trends in infective endocarditis: A population-based study in Olmsted County, Minnesota, JAMA, 293, pp. 3022-3028, (2005)

[3]

Baddour L.M., Wilson W.R., Baye A.S., Et al., Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Circulation, 111, (2005)

[4]

Delahaye J.P., Poncet P., Malquarti V., Et al., Cerebrovascular accidents in infective endocarditis: Role of anticoagulation, Eur Heart J, 11, pp. 1074-1078, (1990)

[5]

Heiro M., Nikoskelainen J., Engblom E., Et al., Neurologic manifestations of infective endocarditis: A 17-year experience in a teaching hospital in Finland, Arch Intern Med, 160, pp. 2781-2787, (2000)

[6]

Sanfilippo A.J., Picard M.H., Newell J.B., Et al., Echocardiographic assessment of patients with infectious endocarditis: Prediction of risk for complications, J Am Coll Cardiol, 18, pp. 1191-1199, (1991)

[7]

Anavekar N.S., Tleyjeh I.M., Anavekar N.S., Et al., Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis, Clin Infect Dis, 44, pp. 1180-1186, (2007)

[8]

Chan K.L., Dumesnil J.G., Cujec B., Et al., A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis, J Am Coll Cardiol, 42, pp. 775-780, (2003)

[9]

Chan K.L., Tam J., Dumesnil J.G., Et al., Effect of long-term aspirin use on embolic events in infective endocarditis, Clin Infect Dis, 46, pp. 37-41, (2008)

[10]

Sedlacek M., Gemery J.M., Cheung A.L., Et al., Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters, Am J Kidney Dis, 49, pp. 401-408, (2007)

← 1 2 3 →